Concepedia

Publication | Open Access

Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study

DOIFull Paper Access

266

Citations

31

References

2019

Year

Emmanuel Bachy, John F. Seymour, Pierre Feugier, Fritz Offner, Armando López‐Guillermo, David Belada, Luc Xerri, John Catalano, Pauline Brice, François Lemonnier,
Journal of Clinical Oncology

Abstract

Rituximab maintenance after induction immunochemotherapy provides a significant long-term PFS, but not OS, benefit over observation.

References

YearCitations

Page 1